Gain and loss of function assays demonstrated that upregulating MAPK8IP1P2 inhibited, while silencing MAPK8IP1P2 promoted anoikis resistance in vitro and lymphatic metastasis of thyroid cancer cells in vivo. Here, MAPK8IP1P2 is linked to thyroid gland carcinoma.